These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
158 related articles for article (PubMed ID: 30374918)
21. Editorial Comment to Endoglin expression in upper urinary tract urothelial carcinoma is associated with intravesical recurrence after radical nephroureterectomy. Zhang Z; Zhou F Int J Urol; 2015 May; 22(5):467-8. PubMed ID: 25808233 [No Abstract] [Full Text] [Related]
22. Percutaneous nephroscopic management of upper urinary tract transitional cell carcinoma: recurrence and long-term followup. Palou J; Piovesan LF; Huguet J; Salvador J; Vicente J; Villavicencio H J Urol; 2004 Jul; 172(1):66-9. PubMed ID: 15201739 [TBL] [Abstract][Full Text] [Related]
23. Re: Efficacy of High-intensity Local Treatment for Metastatic Urothelial Carcinoma of the Bladder: A Propensity Score-Weighted Analysis from the National Cancer Data Base. Woldu SL; Lotan Y Eur Urol; 2016 Nov; 70(5):893. PubMed ID: 27498598 [No Abstract] [Full Text] [Related]
24. Re: Efficacy of High-Intensity Local Treatment for Metastatic Urothelial Carcinoma of the Bladder: A Propensity Score-Weighted Analysis from the National Cancer Data Base. Mathieu R; Peyronnet B; Bensalah K Eur Urol; 2016 Nov; 70(5):894. PubMed ID: 27497763 [No Abstract] [Full Text] [Related]
25. Clinical significance of preoperative renal function and gross hematuria for intravesical recurrence after radical nephroureterectomy for upper tract urothelial carcinoma. Hashimoto T; Nakashima J; Kashima T; Hirasawa Y; Shimodaira K; Gondo T; Nakagami Y; Namiki K; Horiguchi Y; Ohno Y; Ohori M; Tachibana M Int J Urol; 2017 Feb; 24(2):111-116. PubMed ID: 27875859 [TBL] [Abstract][Full Text] [Related]
26. The importance of surgical margins in renal cell and urothelial carcinomas. Alemozaffar M; Filson CP; Master VA J Surg Oncol; 2016 Mar; 113(3):316-22. PubMed ID: 26936428 [TBL] [Abstract][Full Text] [Related]
27. Extravesical Pagetoid Spread of Urothelial Carcinoma in Situ. A Report of Five Cases. Akgul M; Bomeisl PB; MacLennan GT Anal Quant Cytopathol Histpathol; 2015 Dec; 37(6):364-8. PubMed ID: 26860012 [TBL] [Abstract][Full Text] [Related]
29. Transitional cell carcinoma in dialysis patients. Ou JH; Pan CC; Lin JS; Tzai TS; Yang WH; Chang CC; Cheng HL; Lin YM; Tong YC Eur Urol; 2000 Jan; 37(1):90-4. PubMed ID: 10671792 [TBL] [Abstract][Full Text] [Related]
30. Radiofrequency-treated recurrence of urothelial carcinoma of the upper urinary tract after nephroureterectomy. Molina R; Alvarez M; Capilla J; Páez A Korean J Urol; 2014 Dec; 55(12):844-6. PubMed ID: 25512821 [TBL] [Abstract][Full Text] [Related]
31. Re: Impact of Diagnostic Ureteroscopy on Intravesical Recurrence in Patients Undergoing Radical Nephroureterectomy for Upper Tract Urothelial Cancer: A Systematic Review and Meta-Analysis. Laguna MP J Urol; 2018 Apr; 199(4):889-890. PubMed ID: 29642354 [No Abstract] [Full Text] [Related]
32. Risk factors for intravesical recurrence following urothelial carcinoma of the upper urinary tract: no relationship to the mode of surgery. Koda S; Mita K; Shigeta M; Usui T Jpn J Clin Oncol; 2007 Apr; 37(4):296-301. PubMed ID: 17513309 [TBL] [Abstract][Full Text] [Related]
33. Re: Occult Metastases in Pelvic Lymphadenectomy Specimens from Patients with Urothelial Carcinoma of the Bladder. Chang SS J Urol; 2017 May; 197(5):1218-1219. PubMed ID: 29539891 [No Abstract] [Full Text] [Related]
34. Re: Comprehensive Genomic Profiling of 295 Cases of Clinically Advanced Urothelial Carcinoma of the Urinary Bladder Reveals a High Frequency of Clinically Relevant Genomic Alterations. Liedberg F Eur Urol; 2016 Aug; 70(2):400-1. PubMed ID: 27353966 [No Abstract] [Full Text] [Related]
35. Long-term outcomes of complete urinary tract exenteration for dialysis patients with urothelial cancer. Ou CH; Yang WH Int Urol Nephrol; 2017 Apr; 49(4):623-627. PubMed ID: 28161840 [TBL] [Abstract][Full Text] [Related]
36. Bladder recurrence after surgery for upper urinary tract urothelial cell carcinoma: frequency, risk factors, and surveillance. Azémar MD; Comperat E; Richard F; Cussenot O; Rouprêt M Urol Oncol; 2011; 29(2):130-6. PubMed ID: 19762256 [TBL] [Abstract][Full Text] [Related]
37. Muscle-invasive bladder cancer developing after nephroureterectomy for upper urinary tract urothelial carcinoma. Kim KH; You D; Jeong IG; Hong JH; Ahn H; Kim CS Urol Oncol; 2013 Nov; 31(8):1643-9. PubMed ID: 22591745 [TBL] [Abstract][Full Text] [Related]
38. Endoglin expression in upper urinary tract urothelial carcinoma is associated with intravesical recurrence after radical nephroureterectomy. Fujita K; Ujike T; Nagahara A; Uemura M; Tanigawa G; Shimazu K; Fushimi H; Yamaguchi S; Nonomura N Int J Urol; 2015 May; 22(5):463-7. PubMed ID: 25631522 [TBL] [Abstract][Full Text] [Related]
39. [Prognostic factors for intravesical recurrence after surgery for upper tract urothelial carcinoma in renal transplant recipients]. Liu YQ; Lu J; Zhao L; Hou XF; Ma LL Beijing Da Xue Xue Bao Yi Xue Ban; 2015 Aug; 47(4):605-10. PubMed ID: 26284394 [TBL] [Abstract][Full Text] [Related]
40. Re: Comprehensive Genomic Profiling of 295 Cases of Clinically Advanced Urothelial Carcinoma of the Urinary Bladder Reveals a High Frequency of Clinically Relevant Genomic Alterations. Chang SS J Urol; 2017 Feb; 197(2):319. PubMed ID: 28093142 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]